Total Clarity Wealth Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
1,720
-5,690
-77% -$644K 0.04% 331
2026
Q1
$825K Sell
7,410
-1,835
-20% -$217K 0.19% 127
2025
Q4
$1.25M Buy
+9,245
New +$1.01M 0.3% 85

Other funds holding ABVX

Total Clarity Wealth Management's ABVX Position: Q2 2026 in Review

Total Clarity Wealth Management reduced its Abivax (ABVX) stake by 77% in Q2 2026, selling an estimated $644K and leaving 1,720 shares worth $229K. The position accounts for 0.04% of the portfolio, ranked #331.

Total Clarity Wealth Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Total Clarity Wealth Management held 1,720 shares of Abivax worth $229K as of Q2 2026.
  • Total Clarity Wealth Management sold 5,690 Abivax shares in Q2 2026, an estimated $644K.
  • Abivax made up 0.04% of Total Clarity Wealth Management's portfolio in Q2 2026, its #331 holding.
  • Total Clarity Wealth Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Total Clarity Wealth Management's Abivax position peaked at $1.25M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.